Article
Effects of vaccine-acquired polyclonal anti-HBs antibodies on the prevention of HBV infection of non-vaccine genotypes.
Journal of gastroenterology - 1 Sept 2017
Kato Masaki, Hamada-Tsutsumi Susumu, Okuse Chiaki, Sakai Aiko, Matsumoto Nobuyuki, Sato Masaaki, Sato Toshiyuki, Arito Mitsumi, Omoteyama Kazuki, Suematsu Naoya, Okamoto Kazuki, Kato Takanobu, Itoh Fumio, Sumazaki Ryo, Tanaka Yasuhito, Yotsuyanagi Hiroshi, Kato Tomohiro, Kurokawa Manae Suzuki
Abstract excerpt
BACKGROUND: In universal hepatitis B (HB) vaccination, single vaccine-derived polyclonal anti-HBs antibodies (anti-HBs) need to inhibit infection of HB viruses (HBV) of non-vaccine genotypes. We experimentally addressed this issue. METHODS: Anti-HBs-positive sera were obtained by vaccination with genotype A- or C-derived HBs antigen (HBsAg, gtA-sera or gtC-sera). Their reactivity to genotype A- and C-derived...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
